Adorned with the Blade logo, Beta’s ALIA-250 eVTOL soars over Westchester County Airport. [Photo: Blade Air Mobility]
Key Takeaways:
Blade Air Mobility reported strong Q1 2023 financial results, with total revenue up 70%, primarily driven by its highly profitable MediMobility Organ Transplant service, which saw a 111% increase.
While the passenger segment grew in revenue, it experienced a slight adjusted EBITDA loss, mainly due to initial underperformance in Blade Europe, though services like Blade Airport show promise for customer acquisition and future profitability.
Blade is actively testing eVTOL aircraft for future air taxi services but is focused on generating current returns and increasing long-term value through strategic acquisitions, utilizing its strong liquidity, rather than passively waiting for eVTOL commercialization.
Jack is a staff writer covering advanced air mobility, including everything from drones to unmanned aircraft systems to space travel—and a whole lot more. He spent close to two years reporting on drone delivery for FreightWaves, covering the biggest news and developments in the space and connecting with industry executives and experts. Jack is also a basketball aficionado, a frequent traveler and a lover of all things logistics.